•Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
•Honokiol antagonizes cadmium-induced ultrastructural nuclear variation and mitochondrial dysfunction of hepatocytes through targeting Bax protein
•Naltrexone: A safe and effective standard of care in treating alcohol use disorder
•An autopsy case of multiple liver metastases from minute pancreatic acinar cell carcinoma clinically diagnosed as primary hepatic acinar cell carcinoma
•Acute Graft-Versus-Host Disease After Deceased-Donor Liver Transplantation: A Case Report
